Cholesterol Articles

Articles
Bempedoic acid: new evidence and recommendations on use
Paponja K, Pećin I, Reiner Ž, et al.
Journal:
Curr Opin Lipidol

First published: February 1, 2024 DOI: 10.1097/MOL.0000000000000911
View
- Share
Articles
Effect of Intensive Lifestyle Intervention on Cardiovascular Risk Factors: Analysis From the Perspective of Long-Term Variability
He L, Liu M, Zhuang X, et al.
Journal:
J Am Heart Assoc

First published: January 31, 2024 DOI: 10.1161/JAHA.123.030132
View
- Share
Articles
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments
Kastelein JJP, Hsieh A, Dicklin MR, et al.
Journal:
Curr Atheroscler Rep

First published: December 22, 2023 DOI: 10.1007/s11883-023-01184-1
View
- Share
Articles
Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials
Wright RS, Koenig W, Landmesser U, et al.
Journal:
J Am Coll Cardiol

First published: December 12, 2023 DOI: 10.1016/j.jacc.2023.10.007
View
- Share
Articles
Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial
Ray KK, Nicholls SJ, Li N, et al.
Journal:
Lancet Diabetes Endocrinol

First published: December 4, 2023 DOI: 10.1016/S2213-8587(23)00316-9
View
- Share
Articles
National Trends in Racial and Ethnic Disparities in Use of Recommended Therapies in Adults with Atherosclerotic Cardiovascular Disease, 1999-2020
Lu Y, Liu Y, Dhingra LS, et al.
Journal:
JAMA Netw Open

First published: December 1, 2023 DOI: 10.1001/jamanetworkopen.2023.45964
View
- Share
Articles
Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years
Mendieta G, Pocock S, Mass V, et al.
Journal:
J Am Coll Cardiol

First published: November 28, 2023 DOI: 10.1016/j.jacc.2023.09.814
View
- Share
Articles
Bempedoic acid – how will it shape the future lipid-lowering landscape? Mode of action, evidence, and clinical use
Drexel H, Mader A
Journal:
Cardiology

First published: November 21, 2023 DOI: 10.1159/000535372
View
- Share
Articles
Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING randomized trial
Lee B, Hong SJ, Rha SW, et al.
Journal:
Atherosclerosis

First published: November 10, 2023 DOI: 10.1016/j.atherosclerosis.2023.117373
View
- Share
Articles
Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13970 Contemporary High-Risk Patients With Statin Intolerance
Ridker PM, Lei L, Louie MJ, et al.
Journal:
Circulation

First published: November 6, 2023 DOI: 10.1161/CIRCULATIONAHA.123.066213
View
- Share
Articles
Misperceptions and management of LDL-cholesterol in secondary prevention of patients with familial hypercholesterolemia in cardiology practice: Real-life evidence from the EPHESUS registry
Kayıkcioglu M, Başaran Ö, Doğan V, et al.
Journal:
J Clin Lipidol

First published: November 1, 2023 DOI: 10.1016/j.jacl.2023.09.013
View
- Share
Articles
Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study
Wadström BN, Pedersen KM, Wulff AB, et al.
Journal:
Diabetologia

First published: September 30, 2023 DOI: 10.1007/s00125-023-06016-0
View
- Share

1 2 3 … 7

Cholesterol Articles

Articles

Bempedoic acid: new evidence and recommendations on use

Paponja K, Pećin I, Reiner Ž, et al.

Articles

Effect of Intensive Lifestyle Intervention on Cardiovascular Risk Factors: Analysis From the Perspective of Long-Term Variability

He L, Liu M, Zhuang X, et al.

Articles

Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments

Kastelein JJP, Hsieh A, Dicklin MR, et al.

Articles

Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials

Wright RS, Koenig W, Landmesser U, et al.

Articles

Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial

Ray KK, Nicholls SJ, Li N, et al.

Articles

National Trends in Racial and Ethnic Disparities in Use of Recommended Therapies in Adults with Atherosclerotic Cardiovascular Disease, 1999-2020

Lu Y, Liu Y, Dhingra LS, et al.

Articles

Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years

Mendieta G, Pocock S, Mass V, et al.

Articles

Bempedoic acid – how will it shape the future lipid-lowering landscape? Mode of action, evidence, and clinical use

Drexel H, Mader A

Articles

Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING randomized trial

Lee B, Hong SJ, Rha SW, et al.

Articles

Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13970 Contemporary High-Risk Patients With Statin Intolerance

Ridker PM, Lei L, Louie MJ, et al.

Articles

Misperceptions and management of LDL-cholesterol in secondary prevention of patients with familial hypercholesterolemia in cardiology practice: Real-life evidence from the EPHESUS registry

Kayıkcioglu M, Başaran Ö, Doğan V, et al.

Articles

Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study

Wadström BN, Pedersen KM, Wulff AB, et al.

Articles

Bempedoic acid: new evidence and recommendations on use

Paponja K, Pećin I, Reiner Ž, et al.

Share

Articles

Effect of Intensive Lifestyle Intervention on Cardiovascular Risk Factors: Analysis From the Perspective of Long-Term Variability

He L, Liu M, Zhuang X, et al.

Share

Articles

Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments

Kastelein JJP, Hsieh A, Dicklin MR, et al.

Share

Articles

Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials

Wright RS, Koenig W, Landmesser U, et al.

Share

Articles

Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial

Ray KK, Nicholls SJ, Li N, et al.

Share

Articles

National Trends in Racial and Ethnic Disparities in Use of Recommended Therapies in Adults with Atherosclerotic Cardiovascular Disease, 1999-2020

Lu Y, Liu Y, Dhingra LS, et al.

Share

Articles

Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years

Mendieta G, Pocock S, Mass V, et al.

Share

Articles

Bempedoic acid – how will it shape the future lipid-lowering landscape? Mode of action, evidence, and clinical use

Drexel H, Mader A

Share

Articles

Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING randomized trial

Lee B, Hong SJ, Rha SW, et al.

Share

Articles

Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13970 Contemporary High-Risk Patients With Statin Intolerance

Ridker PM, Lei L, Louie MJ, et al.

Share

Articles

Misperceptions and management of LDL-cholesterol in secondary prevention of patients with familial hypercholesterolemia in cardiology practice: Real-life evidence from the EPHESUS registry

Kayıkcioglu M, Başaran Ö, Doğan V, et al.

Share

Articles

Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study

Wadström BN, Pedersen KM, Wulff AB, et al.

Share